#97 - Peter Hotez, M.D., Ph.D.: COVID-19: transmissibility, vaccines, risk reduction, and treatment

Mar 14, 2020 Episode Page ↗
Overview

Dr. Peter Hotez, Dean for the National School of Tropical Medicine, discusses the SARS-CoV-2 virus and COVID-19 disease, emphasizing its high transmissibility and lethality for vulnerable groups. He highlights the US's delayed response and advocates for convalescent plasma therapy and specialized task forces to combat the rapidly evolving pandemic.

At a Glance
5 Insights
57m 1s Duration
14 Topics
6 Concepts

Deep Dive Analysis

Nomenclature: COVID-19 vs. SARS-CoV-2

Historical Context of Coronavirus Pandemics

Distinction Between SARS-1, MERS, and SARS-CoV-2 Transmissibility and Lethality

Vulnerable Populations and Healthcare Worker Risk

Impact of Delayed US Diagnostic Testing

Convalescent Plasma Therapy as an Immediate Intervention

Challenges of Vaccine Development and Immune Enhancement Risk

The ACE2 Receptor and Diverse Pathology of SARS-CoV-2

Fomite Transmission and Virus Survival on Surfaces

Understanding R-naught and Case Fatality Rates

Protecting Vulnerable Older Populations in Nursing Homes

Geographic Areas of Concern in the US and Globally

Hospital Capacity and Potential Bottlenecks

The Importance of Continuous Data Monitoring and Re-evaluation

COVID-19

COVID-19 is the official designated name of the disease by the World Health Organization. It is caused by the SARS-CoV-2 virus.

SARS-CoV-2

SARS-CoV-2 is the causative agent, the virus, that leads to the disease COVID-19. It is similar to the original SARS (SARS-1) from 2003, indicating a shared viral type.

Immune Enhancement

Immune enhancement is a phenomenon where a vaccine could actually make the disease worse, as seen historically with the RSV vaccine in the 1960s and in animal models for SARS-1 vaccines. It means vaccine recipients could experience more severe illness upon exposure to the natural virus.

ACE2 Receptor

The ACE2 receptor is the primary entry point for the SARS-CoV-2 virus into human cells. It is found not only in the lungs but also in the intestinal tract, endothelial cells, and potentially the myocardium, explaining the diverse pathology seen in patients.

Fomite Transmission

Fomite transmission refers to the spread of a virus through contact with contaminated surfaces. SARS-CoV-2 can survive for varying durations on different surfaces, contributing to its transmissibility via droplet contact.

R-naught (R₀)

R-naught, or the basic reproductive number, is a measure of how transmissible an infectious agent is. It refers to the average number of people that will get infected if a single individual has the virus.

?
What is the difference between COVID-19 and SARS-CoV-2?

COVID-19 is the official name of the disease, while SARS-CoV-2 is the name of the virus that causes it, similar to how AIDS is the disease caused by the HIV virus.

?
How does SARS-CoV-2 compare to previous coronavirus pandemics like SARS-1 and MERS?

SARS-CoV-2 is highly transmissible and causes serious disease in certain groups, making it more concerning than SARS-1 or MERS, which were more lethal but less transmissible among the general population due to severe symptoms.

?
Who are the most vulnerable populations to severe illness from SARS-CoV-2?

Individuals over 70, those with underlying disabilities like diabetes, hypertension, or heart disease, and healthcare workers are most vulnerable to serious disease and higher mortality rates.

?
What is convalescent plasma therapy and how could it help with COVID-19?

Convalescent plasma therapy involves collecting serum from recovered patients, which contains antibodies, and using it as a treatment for sick individuals or as prophylaxis for healthcare workers and first responders to prevent them from getting sick.

?
Why is developing a SARS-CoV-2 vaccine challenging and not a near-term solution?

Vaccine development is a lengthy process requiring extensive safety and efficacy testing, typically taking years. Additionally, coronavirus vaccines have historically shown a risk of 'immune enhancement' where the vaccine could potentially worsen the disease in laboratory animals.

?
How long can SARS-CoV-2 survive on common surfaces?

The virus can survive for approximately 72 hours on plastic, 48 hours on cardboard, 24 hours on steel, and 8 to 24 hours on copper surfaces, contributing to fomite transmission.

?
What is the estimated transmissibility (R-naught) and case fatality rate of SARS-CoV-2?

The R-naught is estimated to be between 2.24 and 3.58, meaning each infected person can infect 2 to 4 others. The overall case fatality rate is between 0.6% and 3.4%, but it rises to 10% to 20% for older populations.

?
What are the most concerning geographic regions in the US for SARS-CoV-2 spread?

Any large urban center in the US is vulnerable, as seen in Seattle and New Rochelle, and it is expected that as testing increases, more new foci of infection will be identified across the country.

1. Practice Social Distancing

Implement social distancing now to buy time and shift the curve of infections, which has enormous consequences for healthcare capacity and the ability to provide care.

2. Protect Vulnerable Elderly

Nursing homes and assisted living facilities must implement extra screening measures for people entering and exiting, and review preparedness plans, to protect older residents from the virus’s devastating effects.

3. Implement Convalescent Serum

Identify patients who have recovered from the infection, collect their antibody-rich serum, and use it as a low-cost treatment for seriously ill patients or as prophylaxis for healthcare workers and first responders. This requires the help of blood banks and a federal task force for standardization.

4. Prevent Fomite Transmission

Be aware that the virus can survive on surfaces (e.g., plastic for 72 hours, steel for 24 hours), making droplet contact and auto-inoculation (touching mucous membranes) significant modes of transmission.

5. Scientists Engage Public

Physicians and scientists should actively engage public audiences to counter ignorance and false information, as this is the best weapon against misinformation.

This is the angel of death for older people.

Dr. Peter Hotez

So while it isn't necessarily the most lethal virus we've ever seen, nor is it the most transmissible, it's high in both categories. And that combines in this very unique way.

Dr. Peter Hotez

So the problem is you have a lot of virus circulating and only certain groups seem to be getting serious disease.

Dr. Peter Hotez

Otherwise we go back to the 14th century in terms of using quarantine methods and that kind of thing. And we see what happens when we have to do that. It's not a good look for our country.

Dr. Peter Hotez

All models are wrong, some are useful.

Peter Attia

Confronting a new serious virus pathogen is one of the hardest things our country faces, has faced the last 20 years.

Dr. Peter Hotez
80%
SARS-CoV-2 genetic code similarity to SARS-1 Indicates significant resemblance and binding to the same receptor.
300-600 mLs
Convalescent serum dosage for seriously ill patients Suggests a one-to-one donor per patient ratio for treatment.
5 mLs
Convalescent serum dosage for prophylaxis A single donor could potentially provide prophylaxis for dozens or up to 100 individuals.
72 hours
Virus survival on plastic surfaces Time until the virus reaches a level not compatible with transmission.
48 hours
Virus survival on cardboard surfaces Time until the virus reaches a level not compatible with transmission.
24 hours
Virus survival on steel surfaces Time until the virus reaches a level not compatible with transmission.
8-24 hours
Virus survival on copper surfaces Time until the virus reaches a level not compatible with transmission.
1.2-1.3
Seasonal flu R-naught For comparison to SARS-CoV-2 transmissibility.
12-18
Measles R-naught For comparison to SARS-CoV-2 transmissibility.
10-20%
Case fatality rate for individuals over age 70 Significantly higher mortality rate in older populations.
13 people
Deaths in Kirkland, Washington nursing home outbreak Out of approximately 100 individuals, demonstrating high mortality in vulnerable settings.